{"id":"W4404388316","doi":"10.57264/cer-2024-0118","title":"Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United States","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"LEO Pharma; Otsuka Pharmaceutical; Novo Nordisk; CVS Health; Regeneron Pharmaceuticals; Bayer HealthCare; Sanofi; National Pharmaceutical Council; Centene Corporation; Mallinckrodt Pharmaceuticals; Commonwealth Fund; Alnylam Pharmaceuticals; Kaiser Permanente; GlaxoSmithKline; National Organization for Rare Disorders; Arnold Ventures; AstraZeneca; Patrick and Catherine Weldon Donaghue Medical Research Foundation","keywords":"Medicine; Payment; Finance; Business","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02682567,0.0004605892,0.0007387896,0.001707439,0.003535928,0.01554644,0.001884368,0.01675362,0.007198046],"category_scores_gemma":[0.03661924,0.0003306589,0.0009040234,0.001712736,0.007110564,0.009549973,0.005468704,0.006756564,0.0003317309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01408898,"about_ca_system_score_gemma":0.04530862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01844001,"about_ca_topic_score_gemma":0.02369876,"domain_scores_codex":[0.9867086,0.008117112,0.0004064895,0.0005396396,0.001877892,0.002350187],"domain_scores_gemma":[0.9768909,0.01533942,0.002515686,0.0003780152,0.001817555,0.003058551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001851964,0.0004522433,0.003336654,0.000404426,0.00007073559,0.0002757782,0.001935198,0.004905928,0.0005270339,0.8448869,0.05539961,0.08762033],"study_design_scores_gemma":[0.0004289374,0.0006709424,0.01331318,0.003657263,0.0001668385,0.0002482558,0.0120164,0.01204669,0.0009201055,0.6418247,0.3144992,0.000207417],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.02194332,0.01408997,0.003025871,0.9271852,0.000807106,0.0001013556,0.00006356177,0.00004311375,0.03274049],"genre_scores_gemma":[0.7113383,0.01992637,0.008854267,0.2500533,0.001712996,0.0003793078,0.00007796088,0.00003083955,0.00762667],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02682567,"threshold_uncertainty_score":0.1418694,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1974956848485162,"score_gpt":0.4900226394215382,"score_spread":0.292526954573022,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}